Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Healthcare Biotechnology
Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19... see more

TSXV:VXL - Post Discussion

Vaxil Bio Ltd > Where is ImMucin update ???
View:
Post by bligicka on Sep 15, 2020 10:06am

Where is ImMucin update ???

Cancer is big business, what's next for ImMucin ???
Comment by bligicka on Sep 16, 2020 10:25am
Would be nice to hear of any advances in lmMucin while we wait for data or phase 1 trials or partnerships
Comment by Nighttrade on Sep 16, 2020 3:15pm
Stop replying to your own comments moron.
Comment by Gaslighting on Sep 16, 2020 3:20pm
This post has been removed in accordance with Community Policy
Comment by krisbsj on Sep 16, 2020 6:38pm
And your account was created 2 weeks ago. Right about the same time you started bashing this stock.
Comment by bligicka on Sep 16, 2020 8:07pm
VAXILS IP PORTFOLIO IS DIVIDED INTOTHREE PATENT-FAMILIESVAXIL HOLDS A TOTAL OF6ISSUED PATENTS AND10ADDITIONAL PATENTS PENDING ALL INTELLECTUAL PROPERTY RIGHTS ARE 100% COMPANY OWNED
Comment by burnout29 on Sep 16, 2020 9:01pm
This post has been removed in accordance with Community Policy
Comment by Nighttrade on Sep 17, 2020 2:50am
It's "Stock Club". The fool keeps replying to himself.
Comment by superstockpick on Sep 17, 2020 2:57am
 THE WORD IS SLOWLY GETTING OUT ABOUT VAXIL AND IT'S ENORMOUS VACCINE POTENTIAL, WATCH THE PRICE SLOWLY MOVE UP , AND SEE THE HUGE PHARMA COMPANIES COME OUT WITH EXCUSE AFTER EXCUSE ON WHY THEY HAVE NOT YET DEVELOPED A COVID VACCINE,  ***   **** EXCUSES AND OTHER REASONS FOR NO VACCINES WILL BE ISSUED FROM THESE COMPANIES AND  WILL START POPPING UP BY 2021 ...more  
Comment by RapsAlot on Sep 17, 2020 9:16pm
I still remember the good old days when Putin claimed he had a vaccine. 
Vaxil Bio Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities